1.Prokaryotic expression, purification and immunogenicity of SARS-CoV-2 omicron variant nucleocapsid protein.
Zewen TU ; Quansheng WANG ; Shiguo LIU ; Haosen LIU ; Chunyan ZENG ; Juanjuan XIE ; Mingzhi LI ; Jingcai LI ; Min WANG ; Shiqi WENG ; Lumei KANG ; Lingbao KONG
Chinese Journal of Cellular and Molecular Immunology 2025;41(8):735-743
Objective The study aims to investigate the immunological functions of the nucleocapsid (N) protein of the novel coronavirus Omicron (BA.1, BA.2) and evaluate the differences among different N proteins of mutant strains in immunogenicity. Methods By aligning sequences, the mutation sites of the Omicron (BA.1, BA.2) N protein relative to prototype strain of the novel coronavirus (Wuhan-Hu-1) were determined. The pET-28a-N-Wuhan-Hu-1 plasmid was used as template to construct pET-28a-BA.1/BA.2-N through single point mutation or homologous recombination. The three kinds of N protein were expressed in prokaryotic system, purified through Ni-NTA affinity chromatography, and then immunized into mice. The titer and reactivity of the polyclonal antibody, as well as the expression level of IL-1β and IFN-γ in mouse spleen cells, were detected using indirect ELISA and Western blot assay. Results The constructed prokaryotic expression plasmids were successfully used to express the Wuhan-Hu-1 N, BA.1 N, and BA.2 N proteins in E.coli BL21(DE3) at 37 DegreesCelsius for 4 hours. The indirect ELISA test showed that the titers of polyclonal antibody prepared by three N proteins were all 1:51 200. All three N proteins can increase the expression of IFN-γ and IL-1β cytokines, but the effect of Omicron N protein in activing two cytokines was more obvious than that of Wuhan-Hu-1 N protein. Conclusion The study obtained three new coronavirus N proteins and polyclonal antibodies, and confirmed that mutations in the amino acid sites of the N protein can affect its immunogenicity. This provides a basis for developing rapid diagnostic methods targeting N protein of different novel coronavirus variants.
Animals
;
Mice
;
SARS-CoV-2/genetics*
;
Coronavirus Nucleocapsid Proteins/immunology*
;
Nucleocapsid Proteins/isolation & purification*
;
COVID-19/immunology*
;
Antibodies, Viral/immunology*
;
Mice, Inbred BALB C
;
Interferon-gamma/metabolism*
;
Interleukin-1beta/metabolism*
;
Female
;
Escherichia coli/metabolism*
;
Mutation
;
Humans
2.A truncated N protein-based ELISA method for the detection of antibodies against porcine deltacoronavirus.
Dongsheng WANG ; Ruiming YU ; Liping ZHANG ; Yingjie BAI ; Xia LIU ; Yonglu WANG ; Xiaohua DU ; Xinsheng LIU
Chinese Journal of Biotechnology 2025;41(7):2760-2773
This study aims to establish an antibody detection method for porcine deltacoronavirus (PDCoV). The recombinant proteins PDCoV-N1 and PDCoV-N2 were expressed via the prokaryotic plasmid pColdII harboring the N gene sequence of the PDCoV strain CH/XJYN/2016. The reactivity and specificity of PDCoV-N1 and PDCoV-N2 with anti-PEDV sera were analyzed after the recombinant proteins were analyzed by SDS-PAGE and purified by the Ni-NTA Superflow Cartridge. Meanwhile, Western blotting and indirect immunofluorescence assay were carried out separately to validate the recombinant proteins PDCoV-N1 and PDCoV-N2. Finally, we established an indirect ELISA method based on the recombinant protein PDCoV-N2 after optimizing the conditions and tested the sensitivity, specificity, and reproducibility of the method. Then, the established method was employed to examine 102 clinical serum samples. The recombinant protein PDCoV-N2 showed low cross-reactivity with anti-PEDV sera. The optimal conditions of the indirect ELISA method based on PDCoV-N2 were as follows: the antigen coating concentration of 1.25 μg/mL and coating at 37 ℃ for 1 h; blocking by BSA overnight at 4 ℃; serum sample dilution at 1:50 and incubation at 37 ℃ for 1 h; secondary antibody dilution at 1:80 000 and incubation at 37 ℃ for 1 h; color development with TMB chromogenic solution at 37 ℃ for 10 min. The S/P value ≥ 0.45, ≤0.38, and between 0.45 and 0.38 indicated that the test sample was positive, negative, and suspicious, respectively. The testing results of the antisera against porcine epidemic diarrhea virus (PEDV), porcine circovirus 2 (PCV2), transmissible gastroenteritis virus (TGEV), foot-and-mouth disease virus (FMDV), and African swine fever virus (ASFV) showed that the S/P values were all less than 0.38. The testing results of the 800-fold diluted anti-PDCoV sera were still positive. The results of the inter- and intra-batch tests showed that the coefficients of variation of this method were less than 10%. Clinical serum sample test results showed the coincidence rate between this method and neutralization test was 94.12%. In this study, an ELISA method for the detection of anti-PDCoV antibodies was successfully established based on the truncated N protein of PDCoV. This method is sensitive, specific, stable, and reproducible, serving as a new method for the clinical diagnosis of PDCoV.
Animals
;
Enzyme-Linked Immunosorbent Assay/methods*
;
Swine
;
Antibodies, Viral/blood*
;
Recombinant Proteins/genetics*
;
Deltacoronavirus/isolation & purification*
;
Coronavirus Infections/virology*
;
Swine Diseases/diagnosis*
;
Coronavirus Nucleocapsid Proteins
;
Sensitivity and Specificity
3.Research progress in vaccines of SARS-CoV-2.
Xinbin GE ; Qigan QU ; Zeguang WANG ; Shungeng ZHANG ; Yan CHI ; Chunhui SHAN ; Ruihan LIU ; Qing ZHAO
Chinese Journal of Cellular and Molecular Immunology 2023;39(10):946-951
Since the outbreak of corona virus disease 2019 (COVID-19), viral strains have mutated and evolved. Vaccine research is the most direct and effective way to control COVID-19. According to different production mechanisms, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines included inactivated virus vaccine, live attenuated vaccine, mRNA vaccine, DNA vaccine, viral vector vaccine, virus-like particle vaccine and protein subunit vaccine. Among them, viral protein subunit vaccine has a wide application prospect due to its high safety and effectiveness. Viral nucleocapsid protein has high immunogenicity and low variability which could be a new direction for vaccine production. We summarized the current development of vaccine research by reviewing the current progress, vaccine safety and vaccine immune efficiency. It is hoped that the proposed possible development strategies could provide a reference for epidemic prevention work in future.
Humans
;
SARS-CoV-2/genetics*
;
COVID-19/prevention & control*
;
Protein Subunits
;
Vaccines, DNA
;
Nucleocapsid Proteins
4.The nucleocapsid protein of rice stripe virus in cell nuclei of vector insect regulates viral replication.
Wan ZHAO ; Junjie ZHU ; Hong LU ; Jiaming ZHU ; Fei JIANG ; Wei WANG ; Lan LUO ; Le KANG ; Feng CUI
Protein & Cell 2022;13(5):360-378
Rice stripe virus (RSV) transmitted by the small brown planthopper causes severe rice yield losses in Asian countries. Although viral nuclear entry promotes viral replication in host cells, whether this phenomenon occurs in vector cells remains unknown. Therefore, in this study, we systematically evaluated the presence and roles of RSV in the nuclei of vector insect cells. We observed that the nucleocapsid protein (NP) and viral genomic RNAs were partially transported into vector cell nuclei by utilizing the importin α nuclear transport system. When blocking NP nuclear localization, cytoplasmic RSV accumulation significantly increased. In the vector cell nuclei, NP bound the transcription factor YY1 and affected its positive regulation to FAIM. Subsequently, decreased FAIM expression triggered an antiviral caspase-dependent apoptotic reaction. Our results reveal that viral nuclear entry induces completely different immune effects in vector and host cells, providing new insights into the balance between viral load and the immunity pressure in vector insects.
Animals
;
Cell Nucleus
;
Hemiptera/metabolism*
;
Insect Vectors/genetics*
;
Insecta
;
Nucleocapsid Proteins/metabolism*
;
Oryza
;
Plant Diseases
;
Tenuivirus/metabolism*
;
Virus Replication
5.Fecal Nucleic Acid Test as a Complementary Standard for Cured COVID-19 Patients.
Mei HAN ; Jing Bo ZOU ; Huan LI ; Xiao Yu WEI ; Song YANG ; Hui Zheng ZHANG ; Peng Sen WANG ; Qian QIU ; Le Le WANG ; Yao Kai CHEN ; Pin Liang PAN
Biomedical and Environmental Sciences 2020;33(12):935-939
Adolescent
;
Adult
;
Aged
;
COVID-19/virology*
;
COVID-19 Nucleic Acid Testing/methods*
;
Child
;
Coronavirus Nucleocapsid Proteins/genetics*
;
Feces/virology*
;
Female
;
Humans
;
Male
;
Middle Aged
;
Phosphoproteins/genetics*
;
RNA, Viral/genetics*
;
SARS-CoV-2/isolation & purification*
;
Young Adult
6.Nucleocapsid protein from porcine epidemic diarrhea virus isolates can antagonize interferon-λ production by blocking the nuclear factor-κB nuclear translocation.
Ying SHAN ; Zi-Qi LIU ; Guo-Wei LI ; Cong CHEN ; Hao LUO ; Ya-Jie LIU ; Xun-Hui ZHUO ; Xing-Fen SHI ; Wei-Huan FANG ; Xiao-Liang LI
Journal of Zhejiang University. Science. B 2018;19(7):570-580
Porcine epidemic diarrhea virus (PEDV) is a highly infectious pathogen that can cause severe diseases in pigs and result in enormous economic losses in the worldwide swine industry. Previous studies revealed that PEDV exhibits an obvious capacity for modulating interferon (IFN) signaling or expression. The newly discovered type III IFN, which plays a crucial role in antiviral immunity, has strong antiviral activity against PEDV proliferation in IPEC-J2 cells. In this study, we aimed to investigate the effect of PEDV nucleocapsid (N) protein on type III IFN-λ. We found that the N proteins of ten PEDV strains isolated between 2013 and 2017 from different local farms shared high nucleotide identities, while the N protein of the CV777 vaccine strain formed a monophyletic branch in the phylogenetic tree. The N protein of the epidemic strain could antagonize type III IFN, but not type I or type II IFN expression induced by polyinosinic-polycytidylic acid (poly(I:C)) in IPEC-J2 cells. Subsequently, we demonstrated that the inhibition of poly(I:C)-induced IFN-λ3 production by PEDV N protein was dependent on the blocking of nuclear factor-κB (NF-κB) nuclear translocation. These findings might help increase understanding of the pathogenesis of PEDV and its mechanisms for evading the host immune response.
Active Transport, Cell Nucleus
;
Animals
;
Coronavirus Infections
;
immunology
;
veterinary
;
virology
;
Genes, Viral
;
Host-Pathogen Interactions
;
immunology
;
Interferons
;
antagonists & inhibitors
;
biosynthesis
;
genetics
;
Interleukins
;
antagonists & inhibitors
;
biosynthesis
;
genetics
;
NF-kappa B
;
metabolism
;
Nucleocapsid Proteins
;
genetics
;
immunology
;
physiology
;
Porcine epidemic diarrhea virus
;
genetics
;
pathogenicity
;
physiology
;
Promoter Regions, Genetic
;
Swine
;
Swine Diseases
;
immunology
;
virology
7.In vitro assembly of Ebola virus nucleocapsid-like complex expressed in E. coli.
Ruchao PENG ; Tengfei ZHU ; Babayemi Olawale OLADEJO ; Abednego Moki MUSYOKI ; Yingzi CUI ; Yi SHI ; Peiyi WANG ; George Fu GAO
Protein & Cell 2016;7(12):888-898
Ebola virus (EBOV) harbors an RNA genome encapsidated by nucleoprotein (NP) along with other viral proteins to form a nucleocapsid complex. Previous Cryo-eletron tomography and biochemical studies have shown the helical structure of EBOV nucleocapsid at nanometer resolution and the first 450 amino-acid of NP (NPΔ451-739) alone is capable of forming a helical nucleocapsid-like complex (NLC). However, the structural basis for NP-NP interaction and the dynamic procedure of the nucleocapsid assembly is yet poorly understood. In this work, we, by using an E. coli expression system, captured a series of images of NPΔ451-739 conformers at different stages of NLC assembly by negative-stain electron microscopy, which allowed us to picture the dynamic procedure of EBOV nucleocapsid assembly. Along with further biochemical studies, we showed the assembly of NLC is salt-sensitive, and also established an indispensible role of RNA in this process. We propose the diverse modes of NLC elongation might be the key determinants shaping the plasticity of EBOV virions. Our findings provide a new model for characterizing the self-oligomerization of viral nucleoproteins and studying the dynamic assembly process of viral nucleocapsid in vitro.
Ebolavirus
;
chemistry
;
genetics
;
metabolism
;
Escherichia coli
;
genetics
;
metabolism
;
Gene Expression
;
Nucleocapsid
;
chemistry
;
genetics
;
metabolism
;
RNA, Viral
;
chemistry
;
genetics
;
metabolism
;
Recombinant Proteins
;
chemistry
;
genetics
;
metabolism
;
Virus Assembly
8.Epidemic of rabies and effect of its vaccine against a dog that consecutively attacked ten people in one day.
Li Dong GAO ; Hong ZHANG ; Liang CAI ; Bo Zhong CHEN ; Yong Lin JIANG ; Yun Zhi LIU ; Xin Jun LV ; Peng Cheng YU ; Shi Xiong HU ; Fu Qiang LIU ; Hao LI ; Ge Ying LI ; Xin Xin SHEN ; Xiao Yan TAO ; Si Yu ZHANG ; Jia Hui LIU ; Qing TANG ; Jun Hua LI
Biomedical and Environmental Sciences 2014;27(1):60-64
Adolescent
;
Adult
;
Animals
;
Bites and Stings
;
Dog Diseases
;
virology
;
Dogs
;
Female
;
Humans
;
Male
;
Middle Aged
;
Nucleocapsid Proteins
;
genetics
;
Phylogeny
;
Post-Exposure Prophylaxis
;
Rabies
;
prevention & control
;
veterinary
;
virology
;
Rabies Vaccines
;
immunology
;
Young Adult
9.Study on serological cross-reactivity of six pathogenic phleboviruses.
Wei WU ; Shuo ZHANG ; Quan-Fu ZHANG ; Chuan LI ; Mi-Fang LIANG ; De-Xin LI
Chinese Journal of Virology 2014;30(4):387-390
This article aimed to study the antigenicity of nucleocapsid proteins (NPs) in six pathogenic phleboviruses and to provide theoretical evidence for the development of serological diagnostic reagents. NPs of six pathogenic phleboviruses were expressed and purified using a prokaryotic expression system and rabbits were immunized with individual recombinant NPs. Cross-reactions among NPs and rabbit sera were determined by both indirect ELISA and Western blotting analyses, and the sera titer was determined by indirect ELISA. Furthermore, sera from SFTS patients were also detected by each recombinant NP as a coating antigen using indirect ELISA. The cross-reactions and the sera titer were subsequently determined. Both the concentration and purity of recombinant NPs of six pathogenic phleboviruses met the standards for immunization and detection. The results of indirect ELISA and Western blotting showed that each anti-phlebovirus NP rabbit immune serum had potential serological cross-reactivity with the other five virus NP antigens. Furthermore, the sera from SFTS patients also had cross-reactivity with the other five NP antigens to a certain extent. Our preliminary study evaluated the antigenicity and immune reactivity of six pathogenic phleboviruses NPs and laid the foundation for the development of diagnostic reagents.
Animals
;
Antibodies, Viral
;
immunology
;
Antigens, Viral
;
genetics
;
immunology
;
Cross Reactions
;
Humans
;
Nucleocapsid Proteins
;
genetics
;
immunology
;
Phlebotomus Fever
;
diagnosis
;
immunology
;
virology
;
Phlebovirus
;
classification
;
genetics
;
immunology
;
isolation & purification
;
Rabbits
10.The nucleoprotein of severe fever with thrombocytopenia syndrome virus processes a stable hexameric ring to facilitate RNA encapsidation.
Honggang ZHOU ; Yuna SUN ; Ying WANG ; Min LIU ; Chao LIU ; Wenming WANG ; Xiang LIU ; Le LI ; Fei DENG ; Hualin WANG ; Yu GUO ; Zhiyong LOU
Protein & Cell 2013;4(6):445-455
Severe fever with thrombocytopenia syndrome virus (SFTSV), a member of the Phlebovirus genus from the Bunyaviridae family endemic to China, is the causative agent of life-threatening severe fever with thrombocytopenia syndrome (SFTS), which features high fever and hemorrhage. Similar to other negative-sense RNA viruses, SFTSV encodes a nucleocapsid protein (NP) that is essential for viral replication. NP facilitates viral RNA encapsidation and is responsible for the formation of ribonucleoprotein complex. However, recent studies have indicated that NP from Phlebovirus members behaves in inhomogeneous oligomerization states. In the present study, we report the crystal structure of SFTSV NP at 2.8 Å resolution and demonstrate the mechanism by which it processes a ringshaped hexameric form to accomplish RNA encapsidation. Key residues essential for oligomerization are identified through mutational analysis and identified to have a significant impact on RNA binding, which suggests that correct formation of highly ordered oligomers is a critical step in RNA encapsidation. The findings of this work provide new insights into the discovery of new antiviral reagents for Phlebovirus infection.
Binding Sites
;
Crystallography, X-Ray
;
Mutation
;
Nucleocapsid Proteins
;
chemistry
;
genetics
;
metabolism
;
Phlebovirus
;
metabolism
;
Protein Binding
;
Protein Multimerization
;
Protein Structure, Quaternary
;
RNA, Viral
;
metabolism
;
Recombinant Proteins
;
biosynthesis
;
chemistry
;
genetics

Result Analysis
Print
Save
E-mail